These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28885651)

  • 1. The practice pattern of anticoagulation prophylaxis for patients undergoing total hip replacement in a major orthopaedic centre; a retrospective review.
    Hamza SH; Reynolds P
    Hip Int; 2018 Mar; 28(2):178-181. PubMed ID: 28885651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization Patterns, Efficacy, and Complications of Venous Thromboembolism Prophylaxis Strategies in Primary Hip and Knee Arthroplasty as Reported by American Board of Orthopedic Surgery Part II Candidates.
    Runner RP; Gottschalk MB; Staley CA; Pour AE; Roberson JR
    J Arthroplasty; 2019 Apr; 34(4):729-734. PubMed ID: 30685257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes and risk factors of thromboprophylaxis with rivaroxaban versus aspirin in patients undergoing hip arthroplasty in low-incidence population: A nationwide study in Korea.
    Kim HA; Lee JY; Park SH; Kang J; Choi KS; Rhie SJ
    Pharmacoepidemiol Drug Saf; 2019 Apr; 28(4):507-514. PubMed ID: 30848013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
    Yhim HY; Lee J; Lee JY; Lee JO; Bang SM
    PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rivaroxaban versus standard of care in venous thromboembolism prevention following hip or knee arthroplasty in daily clinical practice (Spanish data from the international study XAMOS)].
    Granero J; Díaz de Rada P; Lozano LM; Martínez J; Herrera A;
    Rev Esp Cir Ortop Traumatol; 2016; 60(1):44-52. PubMed ID: 26194908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Phase IV Study of Thromboembolic and Bleeding Events Following Hip and Knee Arthroplasty Using Oral Factor Xa Inhibitor.
    Gomez D; Razmjou H; Donovan A; Bansal VB; Gollish JD; Murnaghan JJ
    J Arthroplasty; 2017 Mar; 32(3):958-964. PubMed ID: 27843040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rivaroxaban: a review of its use for the prophylaxis of venous thromboembolism after total hip or knee replacement surgery.
    Duggan ST
    Am J Cardiovasc Drugs; 2012 Feb; 12(1):57-72. PubMed ID: 22272729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rivaroxaban Versus Enoxaparin for Venous Thromboembolism Prophylaxis after Hip and Knee Arthroplasty.
    Charters MA; Frisch NB; Wessell NM; Dobson C; Les CM; Silverton CD
    J Arthroplasty; 2015 Jul; 30(7):1277-80. PubMed ID: 25724111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
    Stevenson M; Scope A; Holmes M; Rees A; Kaltenthaler E
    Health Technol Assess; 2009 Oct; 13 Suppl 3():43-8. PubMed ID: 19846028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rivaroxaban compared with standard thromboprophylaxis after major orthopaedic surgery: co-medication interactions.
    Kreutz R; Haas S; Holberg G; Lassen MR; Mantovani LG; Schmidt A; Turpie AG
    Br J Clin Pharmacol; 2016 Apr; 81(4):724-34. PubMed ID: 26580706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of rivaroxaban after total hip or total knee arthroplasty.
    Kwong LM
    Am J Manag Care; 2011 Feb; 17(1 Suppl):S22-6. PubMed ID: 21517652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Warfarin should not be used for thromboprohylaxis in elective major orthopaedic surgery: a Croatian perspective.
    Kolundžić R; Šimić Jovičić M; Ðinkić M; Petrović T; Crnković T; Trkulja V
    Med Glas (Zenica); 2017 Aug; 14(2):244-249. PubMed ID: 28698538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rivaroxaban for thrombosis prophylaxis in extensive hip and knee operations. Subanalysis of the German cohort (XAMOS-DE) of non-interventional study XAMOS].
    Mouret P; Kreutz R; Deilmann K; Dihlmann A; Holberg G; Haas S
    MMW Fortschr Med; 2017 Oct; 159(Suppl 6):26-33. PubMed ID: 29557090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness of Different Strategies for the Prevention of Venous Thromboembolism After Total Hip Replacement in China.
    Yan X; Gu X; Xu Z; Lin H; Wu B
    Adv Ther; 2017 Feb; 34(2):466-480. PubMed ID: 28000167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rivaroxaban for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis with trial sequential analysis of randomized controlled trials.
    Ning GZ; Kan SL; Chen LX; Shangguan L; Feng SQ; Zhou Y
    Sci Rep; 2016 Mar; 6():23726. PubMed ID: 27020475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of BMI and Gender on Bleeding Events when Rivaroxaban Is Administered for Thromboprophylaxis Following Total Hip and Total Knee Arthroplasty.
    Krauss ES; Cronin M; Dengler N; Simonson BG; Altner K; Daly M; Segal A
    Semin Thromb Hemost; 2019 Mar; 45(2):180-186. PubMed ID: 30566970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Budgetary impact for the National Health System of apixaban prophylaxis of venous thromboembolism in patients undergoing total knee or hip replacement].
    Gómez Arrayas I; Suárez Fernández C; Gómez Cerezo JF; Betegón Nicolás L; de Salas-Cansado M; Rubio-Terrés C
    Rev Esp Salud Publica; 2012 Dec; 86(6):601-12. PubMed ID: 23325135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-dose TB-402 or rivaroxaban for the prevention of venous thromboembolism after total hip replacement. A randomised, controlled trial.
    Verhamme P; Gunn S; Sonesson E; Peerlinck K; Vanassche T; Vandenbriele C; Ageno W; Glazer S; Prins M; Buller H; Tangelder M
    Thromb Haemost; 2013 Jun; 109(6):1091-8. PubMed ID: 23615791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism after lower limb arthroplasty: is chemical prophylaxis still needed?
    Malhotra K; Marciniak JL; Bonczek SJ; Hunt N
    Eur J Orthop Surg Traumatol; 2016 Dec; 26(8):895-899. PubMed ID: 27448284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboembolism Prophylaxis in Hip Arthroplasty: Routine and High Risk Patients.
    Nam D; Nunley RM; Johnson SR; Keeney JA; Clohisy JC; Barrack RL
    J Arthroplasty; 2015 Dec; 30(12):2299-303. PubMed ID: 26182980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.